CBL-MZ is not a single biological entity: evidence from genomic analysis and prolonged clinical follow-up

• Helen Parker,
• Neil Robert McIver-Brown,
• Zadie A. Davis,
• Marina Parry,
• Matthew J.J. Rose-Zerilli,
• Aliki Xochelli,
• Jane Gibson,
• Renata Walewska,
• Jonathan C. Strefford,
• David G. Oscier

Affiliations

Helen Parker

Cancer Genomics, Academic Unit for Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom;

Neil Robert McIver-Brown

Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, United Kingdom;

Zadie A. Davis

Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, United Kingdom;

Marina Parry

Cancer Genomics, Academic Unit for Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom;

Matthew J.J. Rose-Zerilli

Cancer Genomics, Academic Unit for Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom;

Aliki Xochelli

Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece;

Jane Gibson

Biological Sciences, Faculty of Natural and Environmental Sciences, University of Southampton, Southampton, United Kingdom

Renata Walewska

Cancer Genomics, Academic Unit for Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom;; Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, United Kingdom;

Jonathan C. Strefford

Cancer Genomics, Academic Unit for Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom;; Jonathan C. Strefford, Cancer Genomics, MP824, Somers Building, Faculty of Medicine, Southampton General Hospital, Tremona Rd, Southampton SO16 6YD, United Kingdom.

David G. Oscier

Cancer Genomics, Academic Unit for Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom;; Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, United Kingdom;; David G. Oscier, Department of Molecular Pathology, Royal Bournemouth Hospital, Castle Lane East, Bournemouth BH7 7DW, United Kingdom